Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Jan-13 9:32 PM View:  | Martell Ron President and CEO | NeurogesX, Inc. (NGSX) | 01-Jan-13 | Option Exercise | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 04-Dec-12 4:23 PM View: | Ghiglieri Stephen F Exec. V.P., COO & CFO | NeurogesX, Inc. (NGSX) | 01-Dec-12 | Option Exercise | 3,750 | -- | -- | 5% 82.54K to 86.29K | |
| 14-Nov-12 3:45 PM View: | Peroutka Stephen J Vice President and CMO | NeurogesX, Inc. (NGSX) | 09-Nov-12 | Option Exercise | 18,750 | -- | -- | 100% 0 to 18.75K | |
| 05-Sep-12 2:21 PM View: | Markels Michael Senior VP,Commercial & Bus Dev | NeurogesX, Inc. (NGSX) | 01-Sep-12 | Grant | 15,000 | $0.25 | $3,750.00 | 27% 56.21K to 71.21K | (79%) |
| 05-Sep-12 2:17 PM View: | Ghiglieri Stephen F Exec. V.P., COO & CFO | NeurogesX, Inc. (NGSX) | 01-Sep-12 | Grant | 15,000 | $0.25 | $3,750.00 | 22% 67.54K to 82.54K | (79%) |
| 01-Feb-12 7:39 PM View: | Goodwin Bradford S Director 10% Owner | NeurogesX, Inc. (NGSX) | 31-Jan-12 | Grant | 20,000 | $1.01 | $20,200.00 | 27% 75.0K to 95.0K | (96%) |
| 11-Aug-11 10:38 AM View: | Breen Doron | NeurogesX, Inc. (NGSX) | 10-Aug-11 | Market Sale | 82,109 | $2.00 | $164,571.00 | (100%) 82.11K to 0 | 98% |
| 12-Aug-11 6:04 AM View: | Arkin Moshe 10% Owner | NeurogesX, Inc. (NGSX) | 10-Aug-11 | Market Sale Duplicate | 82,109 | $2.00 | $164,571.00 | (100%) 82.11K to 0 | 98% |
| 11-Aug-11 10:38 AM View: | Breen Doron | NeurogesX, Inc. (NGSX) | 09-Aug-11 | Market Sale | 81,359 | $2.15 | $175,174.00 | (50%) 163.47K to 82.11K | 98% |
| 12-Aug-11 6:04 AM View: | Arkin Moshe 10% Owner | NeurogesX, Inc. (NGSX) | 09-Aug-11 | Market Sale Duplicate | 81,359 | $2.15 | $175,174.00 | (50%) 163.47K to 82.11K | 98% |
| 26-Jul-11 8:54 PM View: | Nelsen Robert Director 10% Owner | NeurogesX, Inc. (NGSX) | 26-Jul-11 | Private Purchase | 1,744,190 | $1.65 | $2,877,910.00 | 71% 2.44M to 4.19M | 2% |
| 26-Jul-11 8:56 PM View: | Goodwin Bradford S Director 10% Owner | NeurogesX, Inc. (NGSX) | 26-Jul-11 | Grant | 60,000 | $1.65 | $99,000.00 | 400% 15.0K to 75.0K | 2% |
| 26-Jul-11 8:56 PM View: | Bienaime Jean Jacques Director | NeurogesX, Inc. (NGSX) | 26-Jul-11 | Grant | 11,627 | $1.65 | $19,184.50 | 115% 10.12K to 21.75K | |
| 26-Jul-11 8:55 PM View: | Markels Michael Senior VP,Commercial & Bus Dev | NeurogesX, Inc. (NGSX) | 26-Jul-11 | Grant | 29,069 | $1.65 | $47,963.80 | 119% 24.47K to 53.54K | 2% |
| 26-Jul-11 8:55 PM View: | Ghiglieri Stephen F EVP, COO & CFO | NeurogesX, Inc. (NGSX) | 26-Jul-11 | Grant | 29,069 | $1.65 | $47,963.80 | 81% 35.81K to 64.88K | 2% |
| 25-Jul-11 9:09 PM View: | Arch Venture Fund V Lp 10% Owner | NeurogesX, Inc. (NGSX) | 21-Jul-11 | Market Purchase | 1,744,190 | $1.65 | $2,877,910.00 | 71% 2.44M to 4.19M | (97%) |
| 28-Jun-11 8:50 AM View: | Arkin Moshe 10% Owner | NeurogesX, Inc. (NGSX) | 27-Jun-11 | Market Sale | 1,079 | $2.10 | $2,270.65 | (< 1%) 164.55K to 163.47K | 98% |
| 28-Jun-11 8:54 AM View: | Breen Doron | NeurogesX, Inc. (NGSX) | 27-Jun-11 | Market Sale Duplicate | 1,079 | $2.10 | $2,270.65 | (< 1%) 164.55K to 163.47K | 98% |
| 28-Jun-11 8:54 AM View: | Breen Doron | NeurogesX, Inc. (NGSX) | 24-Jun-11 | Market Sale Duplicate | 7,499 | $2.10 | $15,753.10 | (4%) 172.05K to 164.55K | 98% |
| 28-Jun-11 8:50 AM View: | Arkin Moshe 10% Owner | NeurogesX, Inc. (NGSX) | 24-Jun-11 | Market Sale | 7,499 | $2.10 | $15,753.10 | (4%) 172.05K to 164.55K | 98% |
| 27-Jun-11 8:33 AM View: | Breen Doron | NeurogesX, Inc. (NGSX) | 23-Jun-11 | Market Sale | 50,000 | $2.09 | $104,535.00 | (23%) 222.05K to 172.05K | 98% |
| 27-Jun-11 8:35 AM View: | Arkin Moshe 10% Owner | NeurogesX, Inc. (NGSX) | 23-Jun-11 | Market Sale Duplicate | 50,000 | $2.09 | $104,535.00 | (23%) 222.05K to 172.05K | 98% |
| 20-Jun-11 8:38 AM View: | Arkin Moshe 10% Owner | NeurogesX, Inc. (NGSX) | 16-Jun-11 | Market Sale | 300,000 | $3.20 | $961,380.00 | (57%) 522.05K to 222.05K | 99% |
| 20-Jun-11 7:57 AM View: | Breen Doron | NeurogesX, Inc. (NGSX) | 16-Jun-11 | Market Sale | 399,002 | $3.14 | $1,253,280.00 | (51%) 783.82K to 384.81K | 99% |
| 06-Jun-11 8:19 AM View: | Breen Doron | NeurogesX, Inc. (NGSX) | 03-Jun-11 | Market Sale | 3,300 | $2.22 | $7,326.00 | (1%) 265.07K to 261.77K | 98% |
| 06-Jun-11 8:19 AM View: | Breen Doron | NeurogesX, Inc. (NGSX) | 02-Jun-11 | Market Sale | 17,807 | $2.36 | $42,095.80 | (6%) 282.88K to 265.07K | 98% |
| 02-Jun-11 9:52 AM View: | Breen Doron | NeurogesX, Inc. (NGSX) | 01-Jun-11 | Market Sale | 11,000 | $2.46 | $27,023.70 | (4%) 293.88K to 282.88K | 98% |
| 19-May-11 4:19 PM View: | Tobias Jeffrey K EVP Research & Dev & CMO | NeurogesX, Inc. (NGSX) | 18-May-11 | Market Sale | 1,115 | $2.82 | $3,144.30 | (18%) 6.11K to 5.0K | 98% |
| 19-May-11 4:19 PM View: | Tobias Jeffrey K EVP Research & Dev & CMO | NeurogesX, Inc. (NGSX) | 17-May-11 | Market Sale | 1,333 | $2.73 | $3,639.09 | (18%) 7.45K to 6.11K | 98% |
| 16-May-11 9:05 PM View: | Tobias Jeffrey K EVP Research & Dev & CMO | NeurogesX, Inc. (NGSX) | 16-May-11 | Market Sale | 1,333 | $2.84 | $3,785.72 | (15%) 8.78K to 7.45K | 98% |
| 16-May-11 9:05 PM View: | Tobias Jeffrey K EVP Research & Dev & CMO | NeurogesX, Inc. (NGSX) | 13-May-11 | Market Sale | 733 | $2.81 | $2,059.73 | (9%) 8.18K to 7.45K | 98% |
| 16-May-11 9:05 PM View: | Tobias Jeffrey K EVP Research & Dev & CMO | NeurogesX, Inc. (NGSX) | 12-May-11 | Market Sale | 600 | $2.91 | $1,746.00 | (7%) 8.78K to 8.18K | 98% |
| 10-May-11 7:24 PM View: | Ghiglieri Stephen F EVP, COO & CFO | NeurogesX, Inc. (NGSX) | 06-May-11 | Market Purchase | 6,100 | $3.03 | $18,465.80 | 15% 39.81K to 45.91K | (99%) |
| 30-Mar-11 9:50 AM View: | Breen Doron | NeurogesX, Inc. (NGSX) | 28-Mar-11 | Market Sale | 12,316 | $4.07 | $50,137.20 | (4%) 306.19K to 293.88K | 99% |
| 28-Mar-11 12:03 PM View: | Arkin Moshe 10% Owner | NeurogesX, Inc. (NGSX) | 25-Mar-11 | Market Sale | 120,000 | $4.02 | $482,940.00 | (19%) 642.05K to 522.05K | 99% |
| 28-Mar-11 12:05 PM View: | Breen Doron | NeurogesX, Inc. (NGSX) | 24-Mar-11 | Market Sale | 152,600 | $4.03 | $615,550.00 | (23%) 674.65K to 522.05K | 99% |
| 28-Mar-11 12:03 PM View: | Arkin Moshe 10% Owner | NeurogesX, Inc. (NGSX) | 24-Mar-11 | Market Sale | 32,600 | $4.07 | $132,610.00 | (5%) 674.65K to 642.05K | 99% |
| 25-Mar-11 6:01 PM View: | Arkin Moshe 10% Owner | NeurogesX, Inc. (NGSX) | 23-Mar-11 | Market Sale | 12,100 | $4.01 | $48,536.70 | (2%) 686.75K to 674.65K | 99% |
| 25-Mar-11 6:03 PM View: | Breen Doron | NeurogesX, Inc. (NGSX) | 23-Mar-11 | Market Sale | 33,800 | $4.01 | $135,434.00 | (3%) 1.01M to 980.84K | 99% |
| 02-Mar-11 11:26 AM View: | Breen Doron | NeurogesX, Inc. (NGSX) | 01-Mar-11 | Market Sale | 8,300 | $3.53 | $29,327.20 | (2%) 336.19K to 327.89K | 99% |
| 02-Mar-11 11:26 AM View: | Breen Doron | NeurogesX, Inc. (NGSX) | 28-Feb-11 | Market Sale | 5,808 | $3.87 | $22,453.10 | (2%) 342.0K to 336.19K | 99% |
| 10-Feb-11 9:11 PM View: | Ditonno Anthony A President, CEO & Director Director | NeurogesX, Inc. (NGSX) | 08-Feb-11 | Gift | 5,000 | -- | -- | (5%) 109.62K to 104.62K | |
| 13-Sep-10 11:30 AM View: | Arkin Moshe 10% Owner | NeurogesX, Inc. (NGSX) | 09-Sep-10 | Market Purchase | 30,000 | $5.50 | $165,000.00 | 1% 2.62M to 2.65M | (99%) |
| 20-Jan-11 6:29 PM View: | Ditonno Anthony A President and CEO Director | NeurogesX, Inc. (NGSX) | 24-Aug-10 | Gift | 4,000 | -- | -- | (4%) 113.62K to 109.62K | |
| 20-Aug-10 3:22 PM View: | Markels Michael Senior VP,Commercial & Bus Dev | NeurogesX, Inc. (NGSX) | 19-Aug-10 | Market Purchase | 2,500 | $5.75 | $14,370.00 | 13% 19.3K to 21.8K | (99%) |
| 11-Aug-10 1:47 PM View: | Goodwin Bradford S Director | NeurogesX, Inc. (NGSX) | 10-Aug-10 | Market Purchase | 5,000 | $6.03 | $30,155.00 | 50% 10.0K to 15.0K | (99%) |
| 29-Jul-10 11:23 AM View: | Breen Doron | NeurogesX, Inc. (NGSX) | 01-Jul-10 | Market Purchase | 4,100 | $6.39 | $26,197.40 | < 1% 1.02M to 1.03M | (99%) |
| 29-Jul-10 11:23 AM View: | Breen Doron | NeurogesX, Inc. (NGSX) | 30-Jun-10 | Market Purchase | 10,501 | $6.65 | $69,850.60 | 1% 1.01M to 1.02M | (99%) |
| 29-Jul-10 11:23 AM View: | Breen Doron | NeurogesX, Inc. (NGSX) | 28-Jun-10 | Market Purchase | 7,000 | $7.16 | $50,150.10 | < 1% 1.01M to 1.01M | (99%) |
| 09-Jun-10 3:08 PM View: | Goodwin Bradford S Director | NeurogesX, Inc. (NGSX) | 08-Jun-10 | Market Purchase | 4,000 | $7.18 | $28,725.60 | 67% 6.0K to 10.0K | (99%) |
